Advertisement

Antimicrobial Prophylaxis in Urology: Timing, Dosing, and Duration Studies with special reference to High-risk conditions

  • Thomas C. Gasser
  • Paul O. Madsen
Chapter
Part of the Fortschritte der Urologie und Nephrologie book series (2824, volume 27)

Summary

A study in guinea pigs was performed to investigate the importance of timing, dosage, and duration of antimicrobial prophylaxis in urologic surgery. To simulate highrisk conditions, in one group a foreign body was implanted subcutaneously. The prostate and one kidney were cauterized and bacteremia was induced by intravenous injection of Escherichia coli solution. Various ciprofloxacin regimen were tested.

The results indicate that antimicrobial prophylaxis is beneficial only if administered before or shortly after surgery. Full therapeutic dosage may not be necessary for prophylactic efficacy. Single dose prophylaxis was as effective as multiple doses. Foreign body infection could be prevented by single-dose prophylaxis.

Keywords

Foreign Body Antimicrobial Prophylaxis Urologic Surgery Bacterial Challenge Prophylactic Efficacy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Burke JF (1961) The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 50:161–168PubMedGoogle Scholar
  2. 2.
    Kunin CM, Johansen KS, Worning AM, Daschner FD (1990) Report of a symposium on use and abuse of antibiotics worldwide. Rev Infect Dis 12:12–19PubMedCrossRefGoogle Scholar
  3. 3.
    Zimmerli W, Zak O, Vosbeck K. (1985) Experimental hematogenous infection of subcutanously implanted foreign bodies. Scand J Infect Dis 17: 303–310PubMedGoogle Scholar
  4. 4.
    Sullivan NM, Sutter VL, Finegold SM (1975) Practical aerobic membrane filtration blood culture technique: Development of procedure. J Clin Microbiol 1: 30–36PubMedGoogle Scholar
  5. 5.
    Nielsen OS, Madsen PO (1982) Importance and timing of prophylactic antibiotics in urology with a special reference to growth and kill rates of E. coli in genitourinary organs. J Urol 123: 608–614Google Scholar
  6. 6.
    Kaiser AB (1986) Antimicrobial prophylaxis in surgery. N Engl J Med 315:1129–1138PubMedCrossRefGoogle Scholar
  7. 7.
    Larsen EH, Gasser TC, Madsen PO (1986) Antimicrobial prophylaxis in urologie surgery. Urol Clin N Am 13: 591–604Google Scholar
  8. 8.
    Murphy DM, Stassen L, Carr ME, Gillespie WA, Cafferkey MT, Falkiner FR (1984) Bactaeremia during prostatectomy and other transurethral operations: influence of timing of antibiotic administration. J Clin Pathol 37:673–676PubMedCrossRefGoogle Scholar
  9. 9.
    Robinson MRG, Arudpragasam ST, Sahgal SM, Cross RJ, Akdas A, Fittal B, Sibbald R (1982) Bactaeremia resulting from prostatic surgery: the source of bacteria. Br J Urol 54: 542–546PubMedCrossRefGoogle Scholar
  10. 10.
    Nielsen KT, Madsen PO (1989) Quinolones in Urology. Urol Res 17:117–124PubMedCrossRefGoogle Scholar
  11. 11.
    Malinverni R, Francioli PB, Glauser MP (1987) Comparison of single and multiple doses of prophylactic antibiotics in experimental streptococcus endocarditis. Circulation 76: 376–382PubMedCrossRefGoogle Scholar
  12. 12.
    Hargreave TB, Gould JC, Kinninmonth AWG, Jeffrey RR, Varma JS, Macintyre CCA, Elton RA, Chisholm GD (1984) A randomized trial of 48 hours of prophylactic cefotaxime versus single dose in transurethral prostatic surgery. J Antimicrob Chemother 14 (suppl B): 263–269PubMedGoogle Scholar
  13. 13.
    Grabe M, Forsgren A, Björk T, Hellsten S (1987) Controlled trial of a short and a prolonged course with ciprofloxacin in patients undergoing transurethral prostatic surgery. Eur J Clin Microbiol 6:11–17PubMedCrossRefGoogle Scholar
  14. 14.
    Widmer AF, Wiestner A, Frei R, Zimmerli W (1991) Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob Agents Chemother 35:741–746PubMedGoogle Scholar
  15. 15.
    Hooper DC, Wolfson JS (1991) Fluoroquinolone antimicrobial agents. N Engl J Med 324: 384–394PubMedCrossRefGoogle Scholar
  16. 16.
    Gasser TC, Graversen PH, Madsen PO (1987) Fleroxacin (Ro 23–6240) distribution in canine prostatic tissue and fluids. Antimicrob Agents Chemother 31:1010–1013PubMedGoogle Scholar
  17. 17.
    Nickel JC, Heaton J, Morales A, Costerton JW (1986) Bacterial biofilm in persistent penile pros- thesis-associated infection. J Urol 135: 586–588PubMedGoogle Scholar

Copyright information

© Dr. Dietrich SteinkopffVerlag & Co. KG, Darmstadt 1992

Authors and Affiliations

  • Thomas C. Gasser
    • 1
  • Paul O. Madsen
    • 2
  1. 1.Urologie ClinicsUniversity HospitalBaselSwitzerland
  2. 2.VA HospitalMadisonUSA

Personalised recommendations